2022
DOI: 10.1055/s-0041-1741495
|View full text |Cite
|
Sign up to set email alerts
|

Digital Phenotyping in Clinical Neurology

Abstract: Internet-connected devices, including personal computers, smartphones, smartwatches, and voice assistants, have evolved into powerful multisensor technologies that billions of people interact with daily to connect with friends and colleagues, access and share information, purchase goods, play games, and navigate their environment. Digital phenotyping taps into the data streams captured by these devices to characterize and understand health and disease. The purpose of this article is to summarize opportunities … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
3
1

Relationship

5
5

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 170 publications
0
8
0
Order By: Relevance
“…The field of quantitative phenotyping attempts to fill this gap by using sensors and devices to quantify aspects of motor and cognitive behavior that are important in cerebellar ataxias [5]. There has been increasing interest in the use of inertial measurement units (IMUs) that record accelerometer and gyroscope data to quantify gait or limb movement [6]- [11] features, computer mouse tasks that assess arm motor control [12], and eye tracking devices to quantify eye movement abnormalities [13], [14].…”
Section: Introductionmentioning
confidence: 99%
“…The field of quantitative phenotyping attempts to fill this gap by using sensors and devices to quantify aspects of motor and cognitive behavior that are important in cerebellar ataxias [5]. There has been increasing interest in the use of inertial measurement units (IMUs) that record accelerometer and gyroscope data to quantify gait or limb movement [6]- [11] features, computer mouse tasks that assess arm motor control [12], and eye tracking devices to quantify eye movement abnormalities [13], [14].…”
Section: Introductionmentioning
confidence: 99%
“…There is a great opportunity to reduce the size and cost of ALS trials, increase the population of individuals who can participate, and accelerate the evaluation of promising therapeutics through the development of new categories of sensitive quantitative motor outcome measures [13][14][15] . Quantitative motor outcome measures may be task-based (i.e., measuring behavior during performance of a specific task) or task-free, where an individual's natural behavior is measured passively and continuously at home.…”
Section: Introductionmentioning
confidence: 99%
“…Clinical assessment of ataxia is typically conducted by visual inspection of the neurological exam and assigned a severity score using clinical rating scales such as the Brief Ataxia Rating Scale [BARS, ( 1 )] and the Scale for the Assessment and Rating of Ataxia [SARA, ( 2 )]. Leveraging technology to provide quantitative motor and cognitive assessments can be of great value for early diagnosis, tracking disease progression, and feature characterization of the disease ( 53 ). Although very useful, clinical rating scales rely on subjective human assessments that depend on the experience and perspective of the clinician and, by design, are relatively imprecise as evidenced by poor test-retest and interrater reliability ( 3 5 ).…”
Section: Introductionmentioning
confidence: 99%